8-K/A: Altisource Asset Management Corp Settles Litigation with Luxor Capital, Avoids Delisting

Sentiment:

Settlement Announcement


Altisource Asset Management Corporation (AAMC) has reached a settlement with Luxor Capital, resolving litigation and avoiding delisting from the NYSE American.

Better than expectedThe settlement has increased AAMC's Stockholders Equity to an amount exceeding $6,000,000, which is better than the previous situation where the company was facing delisting.

Summary

  • Altisource Asset Management Corporation (AAMC) has entered into a settlement agreement with Luxor Capital Group and related entities, as well as a separate settlement with former director Nathaniel Redleaf.
  • Luxor has surrendered all 144,212 shares of AAMC Series A Convertible Preferred Stock, effectively voiding the related Securities Purchase Agreement and Certificate of Designations.
  • AAMC will pay Luxor $1,000,000 in cash within five days of the agreement's effective date, plus three promissory notes.
  • The promissory notes are for $2,000,000 due in three years, $3,000,000 due in five years, and $6,000,000 due in eight years.
  • These notes will accrue interest at either 7.5% on a cash basis or 10% paid-in-kind (PIK), at AAMC's election.
  • AAMC will also pay Luxor 50% of any proceeds from its damage claims in the Erbey Holding Corporation litigation, up to a cumulative cap of $50,000,000.
  • All related litigations between the parties will be dismissed with prejudice, and mutual releases of claims have been exchanged.
  • The settlement has increased AAMC's Stockholders Equity to over $6,000,000, leading the NYSE to rescind its delisting notice.

Sentiment

Score: 7

Explanation: The settlement is a positive development for AAMC, resolving litigation and avoiding delisting. However, the financial obligations to Luxor are significant and could impact future performance. The sentiment is cautiously optimistic.

Positives

  • The settlement resolves multiple litigations, reducing legal uncertainty for AAMC.
  • The surrender of preferred shares by Luxor simplifies AAMC's capital structure.
  • The rescinding of the delisting notice ensures AAMC's continued trading on the NYSE American.
  • The company has the option to pay interest on the promissory notes in cash or in kind, providing flexibility.
  • The settlement includes mutual releases, preventing future claims related to the settled matters.

Negatives

  • AAMC is obligated to make a $1,000,000 cash payment immediately.
  • AAMC is obligated to pay $11,000,000 in principal through promissory notes over the next eight years.
  • The company is subject to restrictions on stock repurchases and dividends if the PIK option is chosen.
  • AAMC is required to share 50% of any proceeds from the Erbey Holding Corporation litigation with Luxor, up to $50,000,000.
  • The company is subject to certain covenants outlined in the promissory notes.

Risks

  • AAMC's ability to meet its payment obligations under the promissory notes is a risk.
  • The company's financial performance will be impacted by the interest payments on the notes.
  • The potential payout to Luxor from the Erbey Holding Corporation litigation could be significant.
  • The restrictions on stock repurchases and dividends under the PIK option could limit shareholder returns.
  • There is a risk of default under the promissory notes, which could lead to further legal action.

Future Outlook

AAMC aims to enhance shareholder value by focusing on initiatives and resolving legacy issues, as indicated by the settlement with Luxor.

Management Comments

  • We are pleased to announce AAMCs global resolution of these matters relating to Luxor said William Erbey, Chairman and CEO of AAMC.
  • This represents a positive start to 2024 as we continue to focus and work hard on initiatives to enhance shareholder value going forward.

Industry Context

This settlement is significant for AAMC as it resolves long-standing litigation and avoids delisting, which could have severely impacted investor confidence. The company's focus on private credit and alternative assets positions it in a niche market, and this settlement allows it to move forward with its business strategy.

Comparison to Industry Standards

  • The settlement terms, including the use of promissory notes with both cash and PIK interest options, are not uncommon in complex financial restructurings.
  • The 50% payout of litigation proceeds to Luxor is a significant portion, but it is capped at $50 million, which is a common practice in settlement agreements.
  • The increase in stockholders' equity to over $6 million is a positive development, as it addresses the NYSE's concerns about AAMC's financial health.
  • Comparable companies in similar situations often face similar challenges in resolving litigation and maintaining listing status, and this settlement is a positive step for AAMC.

Legal Proceedings

  • The settlement resolves litigation with Luxor Capital Group and related entities.
  • The settlement also resolves separate litigation with former AAMC director Nathaniel Redleaf.
  • AAMC is involved in litigation brought by Erbey Holding Corporation pending in USVI Superior Court with case number SX-2018-CV-146.

Stakeholder Impact

  • Shareholders will benefit from the resolution of litigation and the avoidance of delisting.
  • Creditors will be impacted by the new debt obligations to Luxor.
  • Employees will benefit from the increased stability of the company.
  • Customers and suppliers will likely see no immediate impact from this settlement.

Next Steps

  • AAMC will make a $1,000,000 cash payment to Luxor within five business days.
  • AAMC will issue three promissory notes to Luxor.
  • AAMC will dismiss the related litigations with prejudice.
  • AAMC will continue to pursue its damage claims in the Erbey Holding Corporation litigation.
  • AAMC will focus on initiatives to enhance shareholder value.

Key Dates

DateDescription
March 13, 2014Date of the Securities Purchase Agreement (SPA) between Luxor and AAMC.
March 17, 2014Date of the Certificate of Designations attached to the SPA.
August 30, 2018Luxor sold 5,788 Preferred Shares to a third party.
January 31, 2020Luxor sent redemption notices to AAMC for all remaining Preferred Shares.
November 30, 2023NYSE issued a delisting notice to AAMC.
January 11, 2024Effective date of the Settlement Agreement.
January 16, 2024AAMC issued a press release announcing the settlement agreement.

Keywords

settlement, litigation, preferred stock, promissory notes, delisting, Luxor Capital, stockholders equity, NYSE American, Erbey Holding Corporation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.